Last reviewed · How we verify

Investigational aQIVc — Competitive Intelligence Brief

Investigational aQIVc (Investigational aQIVc) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Influenza vaccine (quadrivalent, cell-based). Area: Immunology / Infectious Disease.

phase 3 Influenza vaccine (quadrivalent, cell-based) Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Investigational aQIVc (Investigational aQIVc) — Seqirus. aQIVc is a cell-based quadrivalent influenza vaccine designed to provide broader and more durable immune protection against multiple influenza strains.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Investigational aQIVc TARGET Investigational aQIVc Seqirus phase 3 Influenza vaccine (quadrivalent, cell-based)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Influenza vaccine (quadrivalent, cell-based) class)

  1. Seqirus · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Investigational aQIVc — Competitive Intelligence Brief. https://druglandscape.com/ci/investigational-aqivc. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: